The Food and Drug Administration (FDA) says it is working closely with the Centers for Disease Control and Prevention (CDC) and state health agencies to investigate a multi-state outbreak of listeriosis. At least 15 people infected with the outbreak strain of Listeria monocytogenes have been reported in Colorado, Nebraska, Oklahoma and Texas.
State and local public health officials have interviewed most of the patients and discovered that the majority of them consumed whole cantaloupes, most likely marketed from the Rocky Ford growing region of Colorado.
FDA investigators along with state health officials are working quickly to determine where in the supply chain the contamination most likely occurred and where potentially contaminated product may have been distributed. Both FDA and state public health officials have collected product and environmental samples. Laboratory testing is underway.
Listeriosis is a rare and serious illness caused by eating food contaminated with bacteria called Listeria. People who think they might have become ill should consult their doctor. A person with listeriosis usually has fever and muscle aches. Almost everyone who is diagnosed with listeriosis has "invasive" infection, in which the bacteria spread beyond the gastrointestinal tract.
Listeriosis can be fatal, especially in certain high-risk groups. These groups include older adults, people with compromised immune systems and certain chronic medical conditions (such as cancer). In pregnant women, listeriosis can cause miscarriage, stillbirth, and serious illness or death in newborn babies, though the mother herself rarely becomes seriously ill.
As FDAs investigation continues, the agency will provide updates as warranted.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
Announcing the 2024 Infection Control Today Educator of the Year: Shahbaz Salehi, MD, MPH, MSHIA
December 17th 2024Shahbaz Salehi, MD, MPH, MSHIA, is the Infection Control Today 2024 Educator of the Year. He is celebrated for his leadership, mentorship, and transformative contributions to infection prevention education and patient safety.
Pula General Hospital Celebrates Clean Hospitals
December 16th 2024Learn how Pula General Hospital in Croatia championed infection prevention and environmental hygiene and celebrated Clean Hospitals Day to honor cleaning staff and promote advanced practices for exceptional patient care and safety.
Understanding NHSN's 2022 Rebaseline Data: Key Updates and Implications for HAI Reporting
December 13th 2024Discover how the NHSN 2022 Rebaseline initiative updates health care-associated infection metrics to align with modern health care trends, enabling improved infection prevention strategies and patient safety outcomes.